Literature DB >> 15704000

Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat.

Giuliana Silvestrini1, Paola Ballanti, Francesca Patacchioli, Martina Leopizzi, Novella Gualtieri, Paola Monnazzi, Elisa Tremante, Daniela Sardella, Ermanno Bonucci.   

Abstract

Osteoprotegerin (OPG) and the receptor activator of nuclear factor (NF)-kB ligand (RANKL) are key regulators of osteoclastogenesis. The present study had the main aim of showing the localization of OPG and RANKL mRNA and protein in serial sections of the rat femurs and tibiae by immunohistochemistry (IHC) and in situ hybridization (ISH). The main results were: (1) OPG and RANKL mRNA and protein were co-localized in the same cell types, (2) maturative/hypertrophic chondrocytes, osteoblasts, lining cells, periosteal cells and early osteocytes were stained by both IHC and ISH, (3) OPG and RANKL proteins were mainly located in Golgi areas, and the ISH reaction was especially visible in active osteoblasts, (4) immunolabeling was often concentrated into cytoplasmic vacuoles of otherwise negative proliferative chondrocytes; IHC and ISH labeling increased from proliferative to maturative/hypertrophic chondrocytes, (5) the newly laid down bone matrix, cartilage-bone interfaces, cement lines, and trabecular borders showed light OPG and RANKL immunolabeling, (6) about 70% of secondary metaphyseal bone osteocytes showed OPG and RANKL protein expression; most of them were ISH-negative, (7) osteoclasts were mostly unstained by IHC and variably labeled by ISH. The co-expression of OPG and RANKL in the same bone cell types confirms their strictly coupled action in the regulation of bone metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15704000     DOI: 10.1007/s10735-004-3839-1

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  20 in total

1.  Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand.

Authors:  J Xu; J W Tan; L Huang; X H Gao; R Laird; D Liu; S Wysocki; M H Zheng
Journal:  J Bone Miner Res       Date:  2000-11       Impact factor: 6.741

Review 2.  The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Authors:  L C Hofbauer; S Khosla; C R Dunstan; D L Lacey; W J Boyle; B L Riggs
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

Authors:  V Kartsogiannis; H Zhou; N J Horwood; R J Thomas; D K Hards; J M Quinn; P Niforas; K W Ng; T J Martin; M T Gillespie
Journal:  Bone       Date:  1999-11       Impact factor: 4.398

5.  Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells.

Authors:  U M Malyankar; M Scatena; K L Suchland; T J Yun; E A Clark; C M Giachelli
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

6.  The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.

Authors:  H Komuro; T Olee; K Kühn; J Quach; D C Brinson; A Shikhman; J Valbracht; L Creighton-Achermann; M Lotz
Journal:  Arthritis Rheum       Date:  2001-12

7.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Authors:  D M Anderson; E Maraskovsky; W L Billingsley; W C Dougall; M E Tometsko; E R Roux; M C Teepe; R F DuBose; D Cosman; L Galibert
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

8.  Localization of osteoprotegerin (OPG) on bone surfaces and cement lines in rat tibia.

Authors:  Hiroaki Nakamura; Takehito Tsuji; Azumi Hirata; Toshio Yamamoto
Journal:  J Histochem Cytochem       Date:  2002-07       Impact factor: 2.479

9.  Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

Authors:  Hirayuki Enomoto; Satoko Shiojiri; Kazuto Hoshi; Tatsuya Furuichi; Ryo Fukuyama; Carolina A Yoshida; Naoko Kanatani; Reiko Nakamura; Atsuko Mizuno; Akira Zanma; Kazuki Yano; Hisataka Yasuda; Kanji Higashio; Kenji Takada; Toshihisa Komori
Journal:  J Biol Chem       Date:  2003-04-15       Impact factor: 5.157

10.  A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.

Authors:  J M Quinn; J Elliott; M T Gillespie; T J Martin
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

View more
  41 in total

1.  Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue.

Authors:  Luis Cardoso; Brad C Herman; Olivier Verborgt; Damien Laudier; Robert J Majeska; Mitchell B Schaffler
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

Review 2.  Intercellular cross-talk among bone cells: new factors and pathways.

Authors:  Natalie A Sims; Nicole C Walsh
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

3.  Effects of manganese deficiency on the microstructure of proximal tibia and OPG/RANKL gene expression in chicks.

Authors:  Ran Liu; Cong Jin; Zhenyong Wang; Zhaojun Wang; Jian Wang; Lin Wang
Journal:  Vet Res Commun       Date:  2015-01-30       Impact factor: 2.459

Review 4.  The osteocyte: an endocrine cell ... and more.

Authors:  Sarah L Dallas; Matthew Prideaux; Lynda F Bonewald
Journal:  Endocr Rev       Date:  2013-04-23       Impact factor: 19.871

Review 5.  Wnt/β-catenin Signaling in Osteoarthritis and in Other Forms of Arthritis.

Authors:  Yachuan Zhou; Tingyu Wang; John L Hamilton; Di Chen
Journal:  Curr Rheumatol Rep       Date:  2017-09       Impact factor: 4.592

6.  Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model.

Authors:  Baoli Wang; Hongting Jin; Mei Zhu; Jia Li; Lan Zhao; Yejia Zhang; Dezhi Tang; Guozhi Xiao; Lianping Xing; Brendan F Boyce; Di Chen
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

7.  Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.

Authors:  Jinhu Xiong; Marilina Piemontese; Jeff D Thostenson; Robert S Weinstein; Stavros C Manolagas; Charles A O'Brien
Journal:  Bone       Date:  2014-06-14       Impact factor: 4.398

8.  The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial.

Authors:  Pooneh Salari Sharif; Mahsa Asalforoush; Fatemeh Ameri; Bagher Larijani; Mohammad Abdollahi
Journal:  Age (Dordr)       Date:  2009-12-05

9.  Commitment to the osteoblast lineage is not required for RANKL gene expression.

Authors:  Carlo Galli; Qiang Fu; Wenfang Wang; Bjorn R Olsen; Stavros C Manolagas; Robert L Jilka; Charles A O'Brien
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

Review 10.  Control of RANKL gene expression.

Authors:  Charles A O'Brien
Journal:  Bone       Date:  2009-08-27       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.